The content on this site is intended for healthcare professionals only
Dr Jesus Fabregas speaks to ecancer at the Best of ASCO®️ 2024 Miami Symposium about his highlights in gastrointestinal tumour research from this year’s meeting.
He explains the rationale and results from the ESOPEC, Checkmate-8HW and PASS-01 trials - highlighting them as the most promising from this meeting.
Dr Fabregas believes that we need to build on these trials and gain for information on these treatment combinations before deciding what to do with patients in the clinic.
Enhancing cancer management: The role of oncology pharmacists in Kenya
Addressing Breast Cancer Disparities in Africa
Strengthening comprehensive cancer program and monitoring in Indonesia by tele-mentoring ECHO
Made to measure: Choosing the optimal regimen in transplant-eligible NDMM
Cancer in emergencies: What can we do better to protect the most vulnerable?
Tele-mentoring: Impact of project ECHO
Powering equity in cancer care through digital health
Enhancing head and neck oncology: Key insights from the conference
Choosing Wisely in endometrial & cervix cancers: Medical therapy
